Stratification of randomization is not required for a pre-specified subgroup analysis.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 43, doi. 10.1002/pst.1550
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2013 AND VI 12 AND IP 1
Results: 7
1
2
Confidence intervals for the difference in paired Youden indices.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 17, doi. 10.1002/pst.1543
- By:
- Publication type:
- Article
3
A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 1, doi. 10.1002/pst.1547
- By:
- Publication type:
- Article
4
Evaluating dynamic treatment strategies: does it have to be more costly?
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 35, doi. 10.1002/pst.1546
- By:
- Publication type:
- Article
5
Sample size determination for clinical trials with co-primary outcomes: exponential event times.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 28, doi. 10.1002/pst.1545
- By:
- Publication type:
- Article
6
Corrected profile likelihood confidence interval for binomial paired incomplete data.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 48, doi. 10.1002/pst.1551
- By:
- Publication type:
- Article
7
On the practical application of mixed effects models for repeated measures to clinical trial data.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 1, p. 7, doi. 10.1002/pst.1548
- By:
- Publication type:
- Article